HOUSTON, April 07, 2026 (GLOBE NEWSWIRE)-- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and ...
BioMérieux, a France-based in vitro diagnostics firm, claims its new Tempo EB deliversan Enterobacteriaceae count, including confirmation, in as little as 22 hours. The traditional EN-ISO 21528-2 ...
HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results